Fate Therapeutics (FATE) PT Raised to $31 at SVB Leerink
Tweet
Share
E-mailGet Alerts FATE Hot Sheet
Price: $2.33 -4.9%
Rating Summary:
11 Buy, 13 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Rating Summary:
11 Buy, 13 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 6 | New: 26
Join SI Premium – FREE
SVB Leerink analyst Daina Graybosch raised the price target on Fate Therapeutics (NASDAQ: FATE) to $31.00 (from $20.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Stella International Holdings (1836:HK) (SLNLF) PT Lowered to HK$10 at Macquarie
- OPT Machine Vision Tech Co Ltd (688686:CH) PT Raised to RMB147.60 at Macquarie
- Kuaishou Technology (1024:HK) PT Lowered to HK$27.60 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
